Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Crystal structure of inhibitor of κB kinase β.

Xu G, Lo YC, Li Q, Napolitano G, Wu X, Jiang X, Dreano M, Karin M, Wu H.

Nature. 2011 Apr 21;472(7343):325-30. doi: 10.1038/nature09853. Epub 2011 Mar 20.

2.

Sensitivity and gene expression profile of fresh human acute myeloid leukemia cells exposed ex vivo to AS602868.

Jordheim LP, Plesa A, Dreano M, Cros-Perrial E, Keime C, Herveau S, Demangel D, Vendrell JA, Dumontet C.

Cancer Chemother Pharmacol. 2011 Jul;68(1):97-105. doi: 10.1007/s00280-010-1458-y. Epub 2010 Sep 16.

PMID:
20844879
3.

An adiponectin-like molecule with antidiabetic properties.

Sulpice T, Prunet-Marcassus B, Molveaux C, Cani PD, Vitte PA, Graber P, Dreano M, Burcelin R.

Endocrinology. 2009 Oct;150(10):4493-501. doi: 10.1210/en.2008-1768. Epub 2009 Jul 16.

PMID:
19608652
4.

NF-kappaB inhibition triggers death of imatinib-sensitive and imatinib-resistant chronic myeloid leukemia cells including T315I Bcr-Abl mutants.

Lounnas N, Frelin C, Gonthier N, Colosetti P, Sirvent A, Cassuto JP, Berthier F, Sirvent N, Rousselot P, Dreano M, Peyron JF, Imbert V.

Int J Cancer. 2009 Jul 15;125(2):308-17. doi: 10.1002/ijc.24294.

5.

IL-6 Promotes compensatory liver regeneration in cirrhotic rat after partial hepatectomy.

Tiberio GA, Tiberio L, Benetti A, Cervi E, Montani N, Dreano M, Garotta G, Cerea K, Steimberg N, Pandolfo G, Ferrari-Bravo A, Mazzoleni G, Giulini SM, Schiaffonati L.

Cytokine. 2008 Jun;42(3):372-8. doi: 10.1016/j.cyto.2008.03.012. Epub 2008 May 1.

PMID:
18455423
6.

Pharmacological IKK2 inhibition blocks liver steatosis and initiation of non-alcoholic steatohepatitis.

Beraza N, Malato Y, Vander Borght S, Liedtke C, Wasmuth HE, Dreano M, de Vos R, Roskams T, Trautwein C.

Gut. 2008 May;57(5):655-63. doi: 10.1136/gut.2007.134288.

PMID:
18408102
7.

Interleukin-6 protects against paclitaxel, cisplatin and vincristine-induced neuropathies without impairing chemotherapeutic activity.

Callizot N, Andriambeloson E, Glass J, Revel M, Ferro P, Cirillo R, Vitte PA, Dreano M.

Cancer Chemother Pharmacol. 2008 Nov;62(6):995-1007. doi: 10.1007/s00280-008-0689-7. Epub 2008 Feb 13.

PMID:
18270703
8.

Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.

Sors A, Jean-Louis F, Bégué E, Parmentier L, Dubertret L, Dreano M, Courtois G, Bachelez H, Michel L.

Clin Cancer Res. 2008 Feb 1;14(3):901-11. doi: 10.1158/1078-0432.CCR-07-1419.

9.

Preclinical targeting of NF-kappaB and FLT3 pathways in AML cells.

Griessinger E, Frelin C, Cuburu N, Imbert V, Dageville C, Hummelsberger M, Sirvent N, Dreano M, Peyron JF.

Leukemia. 2008 Jul;22(7):1466-9. doi: 10.1038/sj.leu.2405102. Epub 2008 Jan 31. No abstract available.

PMID:
18239622
10.

Pharmacological targeting of NF-kappaB potentiates the effect of the topoisomerase inhibitor CPT-11 on colon cancer cells.

Lagadec P, Griessinger E, Nawrot MP, Fenouille N, Colosetti P, Imbert V, Mari M, Hofman P, Czerucka D, Rousseau D, Berard E, Dreano M, Peyron JF.

Br J Cancer. 2008 Jan 29;98(2):335-44. doi: 10.1038/sj.bjc.6604082. Epub 2008 Jan 8.

11.

Canonical nuclear factor kappaB pathway inhibition blocks myeloma cell growth and induces apoptosis in strong synergy with TRAIL.

Romagnoli M, Desplanques G, Maïga S, Legouill S, Dreano M, Bataille R, Barillé-Nion S.

Clin Cancer Res. 2007 Oct 15;13(20):6010-8.

12.

Interleukin-6 sustains hepatic regeneration in cirrhotic rat.

Tiberio GA, Tiberio L, Benetti A, Cervi E, Pandolfo G, Dreano M, Garotta G, Comini L, Martini M, Giulini SM, Schiaffonati L.

Hepatogastroenterology. 2007 Apr-May;54(75):878-83.

PMID:
17591083
13.

Targeting NF-kappaB pathway with an IKK2 inhibitor induces inhibition of multiple myeloma cell growth.

Jourdan M, Moreaux J, Vos JD, Hose D, Mahtouk K, Abouladze M, Robert N, Baudard M, Rème T, Romanelli A, Goldschmidt H, Rossi JF, Dreano M, Klein B.

Br J Haematol. 2007 Jul;138(2):160-8. Epub 2007 Jun 3.

14.

AS602868, a dual inhibitor of IKK2 and FLT3 to target AML cells.

Griessinger E, Imbert V, Lagadec P, Gonthier N, Dubreuil P, Romanelli A, Dreano M, Peyron JF.

Leukemia. 2007 May;21(5):877-85. Epub 2007 Mar 1.

PMID:
17330097
15.

Mechanisms of interleukin-6 protection against ischemia-reperfusion injury in rat liver.

Tiberio L, Tiberio GA, Bardella L, Cervi E, Cerea K, Dreano M, Garotta G, Fra A, Montani N, Ferrari-Bravo A, Callea F, Grigolato P, Giulini SM, Schiaffonati L.

Cytokine. 2006 May;34(3-4):131-42. Epub 2006 Jun 30.

PMID:
16814559
16.

Interleukin-6 attenuates the development of experimental diabetes-related neuropathy.

Andriambeloson E, Baillet C, Vitte PA, Garotta G, Dreano M, Callizot N.

Neuropathology. 2006 Feb;26(1):32-42.

PMID:
16521477
17.

Acute haemodynamic effects of IL-6 treatment in vivo: involvement of vagus nerve in NO-mediated negative inotropism.

Comini L, Pasini E, Bachetti T, Dreano M, Garotta G, Ferrari R.

Cytokine. 2005 Jun 7;30(5):236-42. Epub 2005 Mar 17.

PMID:
15927847
18.

Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells.

Frelin C, Imbert V, Griessinger E, Peyron AC, Rochet N, Philip P, Dageville C, Sirvent A, Hummelsberger M, Bérard E, Dreano M, Sirvent N, Peyron JF.

Blood. 2005 Jan 15;105(2):804-11. Epub 2004 Sep 28.

PMID:
15454494
19.

IKK2 inhibitor alleviates kidney and wasting diseases in a murine model of human AIDS.

Heckmann A, Waltzinger C, Jolicoeur P, Dreano M, Kosco-Vilbois MH, Sagot Y.

Am J Pathol. 2004 Apr;164(4):1253-62.

20.

Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices.

Pizzi M, Sarnico I, Boroni F, Benarese M, Dreano M, Garotta G, Valerio A, Spano P.

Mol Cell Neurosci. 2004 Feb;25(2):301-11.

PMID:
15019946
21.

Human cytomegalovirus stimulates cellular IKK2 activity and requires the enzyme for productive replication.

Caposio P, Dreano M, Garotta G, Gribaudo G, Landolfo S.

J Virol. 2004 Mar;78(6):3190-5.

22.

AS602868, a pharmacological inhibitor of IKK2, reveals the apoptotic potential of TNF-alpha in Jurkat leukemic cells.

Frelin C, Imbert V, Griessinger E, Loubat A, Dreano M, Peyron JF.

Oncogene. 2003 Nov 6;22(50):8187-94.

PMID:
14603259
23.

Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells.

Valerio A, Ferrario M, Dreano M, Garotta G, Spano P, Pizzi M.

Mol Cell Neurosci. 2002 Dec;21(4):602-15.

PMID:
12504593
24.

Neuroprotective effect of interleukin-6 and IL6/IL6R chimera in the quinolinic acid rat model of Huntington's syndrome.

Bensadoun JC, de Almeida LP, Dréano M, Aebischer P, Déglon N.

Eur J Neurosci. 2001 Dec;14(11):1753-61.

PMID:
11860469
25.

Lymphocyte activation gene-3 induces tumor regression and antitumor immune responses.

Prigent P, El Mir S, Dréano M, Triebel F.

Eur J Immunol. 1999 Dec;29(12):3867-76.

26.

Characterization of the major histocompatibility complex class II binding site on LAG-3 protein.

Huard B, Mastrangeli R, Prigent P, Bruniquel D, Donini S, El-Tayar N, Maigret B, Dréano M, Triebel F.

Proc Natl Acad Sci U S A. 1997 May 27;94(11):5744-9.

27.

Structural predictions for the ligand-binding region of glycoprotein hormone receptors and the nature of hormone-receptor interactions.

Jiang X, Dreano M, Buckler DR, Cheng S, Ythier A, Wu H, Hendrickson WA, el Tayar N.

Structure. 1995 Dec 15;3(12):1341-53.

28.

Concomitant cellular expression of heat shock regulated genes of hepatitis B virus surface antigen and of human growth hormone by a NIH-3T3 cell line.

L'Hote P, Alouani S, Marq JB, Montandon F, Chessebeuf-Padieu M, Dreano M.

Cell Biol Toxicol. 1993 Oct-Dec;9(4):319-32.

PMID:
8039009
29.

Gene expression following transfection of fish cells.

Bearzotti M, Perrot E, Michard-Vanhee C, Jolivet G, Attal J, Theron MC, Puissant C, Dreano M, Kopchick JJ, Powell R, et al.

J Biotechnol. 1992 Nov;26(2-3):315-25.

PMID:
1369156
30.

Expression of heat shock-regulated human growth hormone genes containing or lacking introns by NIH-3T3 and Wish cell lines.

Alouani S, L'Hote P, Marq JB, Houdebine LM, Montandon F, Chessebeuf-Padieu M, Dreano M.

Cell Biol Toxicol. 1992 Apr-Jun;8(2):139-56.

PMID:
1422924
31.

[Immortalization of cultured cells by the Ha-rasEJ oncogene and expression of a gene of biogenetic value].

Montandon F, Cao H, Dreano M, Padieu P.

C R Seances Soc Biol Fil. 1992;186(5):501-6. French.

PMID:
1305898
32.

Maintenance of liver function in long term culture of hepatocytes following in vitro or in vivo Ha-rasEJ transfection.

Fischbach M, Cao HW, Diez Ibanez M, Tsaconas C, Alouani S, Montandon F, el Baraka M, Padieu P, Dreano M, Chessebeuf-Padieu M.

Cell Biol Toxicol. 1991 Oct;7(4):327-45.

PMID:
1794108
33.

Heat-regulated expression of the hepatitis B virus surface antigen in the human Wish cell line.

Dreano M, Fouillet X, Brochot J, Vallet JM, Michel ML, Rungger D, Bromley P.

Virus Res. 1987 Jul;8(1):43-59.

PMID:
3660944
34.

Organization of the Drosophila melanogaster hsp70 heat shock regulation unit.

Amin J, Mestril R, Schiller P, Dreano M, Voellmy R.

Mol Cell Biol. 1987 Mar;7(3):1055-62.

35.

High-level, heat-regulated synthesis of proteins in eukaryotic cells.

Dreano M, Brochot J, Myers A, Cheng-Meyer C, Rungger D, Voellmy R, Bromley P.

Gene. 1986;49(1):1-8.

PMID:
3569912
36.

Expression of poliovirus capsid polypeptide VP1 in Escherichia coli.

van der Werf S, Dréano M, Bruneau P, Kopecka H, Girard M.

Gene. 1983 Jul;23(1):85-93.

PMID:
6311678
37.

Restriction map of poliovirus type 2 cDNA.

Kopecka H, van der Werf S, Bregegere F, Kitamura N, Dreano M, Rothberg PG, Wimmer E, Kourilsky P, Girard M.

Dev Biol Stand. 1981;50:301-9.

PMID:
6176488

Supplemental Content

Loading ...
Support Center